Wednesday, November 18, 2026

#Bundibugyo Virus Disease #Outbreak, #DRC, #Kenya & #Nigeria - Weekly Report No. 27, Data as of 15 Nov. '26 (WHO, summary): 11,432 cases & 5,593 deaths in DRC

 


{Summary}


{Click on Image to Enlarge}

___

Event description

    The Bundibugyo virus disease (BVD) outbreak in the Democratic Republic  of the Congo continues at a high and sustained level of transmission. 

    During epidemiological week 46 (9 – 15 November 2026), 442 confirmed  cases and 239 confirmed deaths were reported, compared with 458 cases and 228 deaths in week 45; the national seven-day average has remained between 62 and  65 cases per day, and a new health zone, Watsa in Haut-Uélé, reported  its first confirmed cases. 

    Over three epidemiological weeks (weeks 44 – 46 compared with weeks 41  – 43), reported cases decreased by 6.7% and deaths by 4.6%, with a  decline in Ituri partly offset by continued intense transmission in Nord-Kivu, where  Beni remains the health zone with the most cases, and by rising incidence  in Mangala, Mambasa and Mutwanga. 

    Deaths in treatment centres increased in week 46 and the proportion of  deaths occurring in the community fell to 59% (142 of 239), its lowest weekly  level since August. 

    In Kenya, the last patient was discharged on 11 November, and all  contacts have completed their follow-up; the 42-day countdown is under way, and  the event has not yet been declared over. 

    In Nigeria, all 62 contacts completed their 21-day follow-up on 13  November and no secondary case was identified; surveillance continues in both countries. 

    Additionally, Nigeria started the 42 days countdown on 27 Oct after the  case was medically evacuated to Switzerland on the 26 October 2026.

    In the Democratic Republic of the Congo, insecurity in Beni, Mabalako  and Bafwasende, strikes over unpaid salaries in several provinces and community  resistance to safe burials continue to constrain surveillance and response  operations.


Democratic Republic of the Congo

    As of 15 November 2026, the BVD outbreak in the Democratic Republic of  the Congo has affected 68 health zones and 248 health areas across eight provinces. 

    One new health zone, Watsa in Haut-Uélé, was affected during the  reporting period (two confirmed cases reported on 11 November and seven on 13  November). 

    Since External Situation Report #26, (data as of 7 November), an  additional 512 confirmed cases and 270 confirmed deaths have been reported  between 8 and 15 November, of which 442 cases and 239 deaths during epidemiological week 46 (9 – 15 November). 

    The cumulative total is 11 432 confirmed cases, including 5 593 confirmed deaths [crude case fatality ratio (CFR) 48.9%].

    Among cases with a documented outcome (5 593 deaths and 3 109  recoveries), the case fatality ratio is 64.3%; the outcome of the remaining 2 730  cases is still pending or not yet recorded. 

    Transmission remains highly heterogeneous across affected areas. Ituri  continues to account for the largest proportion of cumulative confirmed cases  (68.9%) and accounted for 227 of the 442 cases reported in week 46 (51.4%),  while Nord-Kivu (25.3% of cumulative cases; CFR 55.4%) accounted for 169  (38.2%). Transmission persists at lower levels in Haut-Uélé (35 cases; 7.9%),  Tshopo (10; 2.3%) and Nord-Ubangi (one case).

    National daily incidence rose steadily from May to its highest levels in late July and mid-August, declined through late September and has fluctuated at  a high plateau since early October. The seven-day moving average ranged  between 62 and 65 confirmed cases per day during week 46 (63.1 on 15  November, compared with 65.4 on 8 November), well below the mid-August peak  of 94 but with no downward trend over the last six weeks. Provincial trends diverged. 

    Ituri reported 227 cases in week 46 compared with 223 in week 45 (seven- day average of 32 cases per day on 15 November), with Mandima, Bunia, Mangala  and Mambasa reporting the most cases, while Nord-Kivu reported 169  cases compared with 202 (24 cases per day on 15 November, down from 29 on 8  November), Beni still reporting the largest numbers in the province. 

    Haut-Uélé  reported 35 cases compared with 24 (13 of them on 13 November, seven in the  newly affected Watsa Health Zone), Tshopo 10 compared with six, and Nord- Ubangi one case in Wapinda. Bas-Uélé, Sud-Kivu and SudUbangi have reported no  case in the last 21 days (Figures 1 and 2). 

    By week of symptom onset (Figure  3), confirmed cases recorded in the DHIS2 line list peaked between late July and  mid-August, remained above 400 per week until mid September and have declined gradually since, to 370 in week 43 and 306 in week 44; weeks 44 to 46 are still incomplete because of the delay between symptom onset and reporting (median five days, 90th percentile 14 days).


{Click on Image to Enlarge}

___

(...)


Trend Analysis (21-day comparison):

    During the most recent three epidemiological weeks (weeks 44 – 46, 26  October – 15 November 2026), a total of 1 369 confirmed cases were reported  nationally, compared with 1 468 during the preceding 21 days (weeks 41 – 43, 5 –  25 October), a decrease of 99 cases (−6.7%). 

    Cases in Ituri decreased from 762 to 670 (−12.1%), accounting for 48.9%  of national cases during the latest period, and in Nord-Kivu from 590 to  580 (−1.7%), accounting for 42.4%. Haut-Uélé increased from 77 to 90 cases  (+16.9%; 6.6% of national cases) and Nord-Ubangi from three to four, while  Tshopo decreased from 33 to 25 (−24.2%). Bas-Uélé, which reported three cases in the preceding period, reported none; SudKivu and Sud-Ubangi reported no case in either period. These weekly and three-week figures are sums of the daily counts published in the national sitreps, as on the COUSP dashboard; the  corresponding differences in cumulative counts (1 372 and 1 457 cases) differ  slightly because retrospectively added cases enter the cumulative totals only.

    During the same period, 706 confirmed deaths were reported nationally,  compared with 740 during weeks 41 – 43 (−4.6%). Deaths decreased from 402 to  355 (−11.7%) in Ituri, from 38 to 35 in Haut-Uélé and from 10 to eight in  Tshopo, but increased from 289 to 308 (+6.6%) in Nord-Kivu, which now  accounts for 43.6% of newly reported deaths (39.1% in the preceding period)  against 50.3% for Ituri. Nord-Ubangi, which reported one death in the preceding  period, reported none. In Nord-Kivu, deaths rose while cases fell slightly, consistent with the province's higher case fatality ratio (55.4%).

(...)

    Transmission remained active in more than two-thirds of the health  zones affected since the start of the outbreak. Of the 68 health zones affected to  date, 48 (70.6%) in five provinces reported at least one new confirmed case  during weeks 44 – 46 (26 October – 15 November): 21 in Ituri, 14 in Nord-Kivu,  six in Haut-Uélé, five in Tshopo and two in NordUbangi. The comparison between  the two 21 days periods covers the 54 health zones that reported at least one  case in either period: incidence increased in 22, decreased in 28 and was  unchanged in four (Mahagi and Nyankunde in Ituri, Alimbongo in Nord-Kivu and  Wapinda in Nord-Ubangi); the remaining 14 zones reported no case in either  period.

    The largest absolute increase occurred in Beni, Nord-Kivu (228 to 273  cases; +19.7%), followed by Mutwanga, Nord-Kivu (28 to 71; +153.6%),  Mangala, Ituri (22 to 63; +186.4%), Mambasa, Ituri (46 to 76; +65.2%), Oicha,  Nord-Kivu (43 to 57; +32.6%), Mongbwalu, Ituri (10 to 22), Isiro, Haut-Uélé (7 to  18), Pawa, Haut-Uélé (19 to 29) and Masereka, Nord-Kivu (7 to 16). Watsa in  Haut-Uélé (nine cases), Kilo (five), Drodro and Kambala (one each) in Ituri and  Yakoma in Nord-Ubangi (four) reported cases after none in the preceding period  (Figure 5). Conversely, the largest decreases were observed in Mandima (257 to  202), Rwampara (71 to 48), Bunia (170 to 149), Nia-Nia (27 to 8), Aru (17 to 1)  and Komanda (18 to 2) in Ituri; Butembo (52 to 23), Katwa (61 to 36) and Mabalako (54 to 34) in Nord-Kivu; and Wamba (47 to 23) in HautUélé. In week 46, Beni (71 cases), Mandima (65) and Bunia (51) reported the most cases, followed by Mangala (31), Oicha (25) and Mambasa (24). Zone-level figures are differences in cumulative confirmed cases between SitReps N°143, N°164 and N°185 and reconcile to the national totals.

    There were 20 health zones without a new case during weeks 44 – 46:  Adja, Ariwara, Aungba, Boga, Damas, Gety and Logo in Ituri; Goma, Kayna and  Manguredjipa in Nord-Kivu; Dungu and Gombari in Haut-Uélé; Lubunga and  WanieRukula in Tshopo; Miti-Murhesa in Sud-Kivu; Buta, Dakwa, Ganga and  Viadana in Bas-Uélé; and Bulu in Sud-Ubangi. Six of them (Damas, Gety and Logo  in Ituri, Manguredjipa in Nord-Kivu, and Dakwa and Ganga in Bas-Uélé) had  reported cases during weeks 41 – 43.

(...)

    Weekly confirmed deaths (Figure 7) have fluctuated between 220 and 290  since mid-October: 286 in week 43 (19 – 25 October), 239 in week 44, 228 in  week 45 and 239 in week 46 (9 – 15 November), an increase of 4.8% over the  preceding week. Community deaths decreased from 149 in week 45 to 142 in  week 46 while deaths in treatment facilities rose from 79 to 97, so that the  proportion of deaths occurring in the community fell from 65.4% to 59.4%, the  lowest weekly share since the week of 17 – 23 August (Figure 8). On 15  November, 18 of the 25 confirmed deaths (72%) occurred in the community.  Although the shift in week 46 suggests that more patients reached treatment  facilities before dying, three in five confirmed deaths still occur outside treatment  facilities, and the increase in deaths in treatment centres also points to late presentation.

(...)


Kenya

    Since the previous report, Kenya has reported no new confirmed case of BVD. The cumulative total remains nine confirmed cases, including two deaths  (CFR 22.2%), all belonging to a single chain of transmission linked to the  imported index case; the last confirmed case was reported on 19 October 2026. 

    On 11 November 2026, the Ministry of Health announced the discharge of  the last patient under treatment, the seventh survivor, after two consecutive  negative tests, and the final 11 contacts completed their 21-day monitoring and  were released from quarantine on the same day. For the first time since the first  case was confirmed, Kenya has no patient under treatment and no contact under  follow-up.

    The 42-day countdown started on 12 November 2026; the end of the  event will be declared by the Government if no new case is detected during that  period. Surveillance, screening at points of entry and survivor follow-up continue. 

(...)


Nigeria

    Nigeria has reported a single confirmed case of BVD, confirmed on 20  October 2026 in the Federal Capital Territory, Abuja, in a traveller from Uganda.  The patient was medically evacuated to Switzerland on 26 October and discharged  from the Geneva University Hospitals on 11 November 2026 after full  recovery; the 42-day countdown is counted from 27 October, the day after the  evacuation. No secondary case has been identified. On 13 November 2026, the  Nigeria Centre for Disease Control and Prevention (NCDC) announced that all 62  contacts of the index case had completed their 21-day follow-up; 13 contacts who  developed fever or non-specific symptoms during monitoring tested  negative, as did seven suspected cases reported from Adamawa, Borno, Ekiti, Lagos and Rivers states over the preceding three weeks.

    The 62 contacts include the companion evacuated with the patient,  whose follow-up in Switzerland was due to end on 16 November according to the  Swiss IHR National Focal Point. The Emergency Operations Centre remains  activated and surveillance continues; the completion of contact monitoring does  not constitute a declaration of the end of the event, which will follow WHO criteria.  

    Two lessons stand out from this event: the rapid activation of the incident  management  system and of response activities once the case was notified and  confirmed, and the 12-day interval between symptom onset and notification, eight  days of which were spent in a private health facility, which underlines the  need for a high index of suspicion among clinicians for travellers from affected areas.

(...)


Situation interpretation 

    The BVD outbreak in the Democratic Republic of the Congo remains at a critical juncture six months after its declaration. 

    Transmission is broadly stable at a high level: 442 confirmed cases and 239  deaths were reported in epidemiological week 46, the national seven-day  average has held between 61 and 76 cases per day since the beginning of  October, and the three-week totals fell marginally, from 1 468 to 1 369 cases  (−6.7%) and from 740 to 706 deaths (−4.6%). 

    The decrease is driven by Ituri, where Mandima, Bunia and Rwampara  reported fewer cases, while Mangala and Mambasa in Ituri and Mutwanga and  Oicha in Nord-Kivu are intensifying, Beni remains the largest focus, Haut-Uélé  reported a new health zone (Watsa), and sporadic transmission continued in Tshopo and Nord-Ubangi. 

    The response is still not reaching the performance required to interrupt transmission: only half of investigated suspected cases are isolated within 24  hours, close to one in six contacts is not seen each day, more than 1 000 contacts  have been lost to follow-up, and three in five deaths still occur in the community,  although the share of community deaths fell in week 46 and safe burial refusals  decreased. 

    Insecurity in Beni, Mabalako and Bafwasende, strikes over unpaid  salaries and shortages of vaccine doses in Nord-Kivu further constrain operations. 

    In Kenya, where eight secondary cases occurred in a single chain, all  contacts have completed follow-up and the 42-day countdown is under way; in  Nigeria, contact monitoring 18 ended on 13 November with no secondary case identified. 

    Neither event has been declared over and surveillance continues in both  countries. Priorities remain reinforcing response capacity in the most active health  zones of Nord-Kivu (Beni, Mutwanga, Oicha) and Ituri (Mandima, Bunia,  Mangala, Mambasa), investigating the new focus in Watsa, improving the  timeliness of isolation of suspected cases and the completeness of contact follow- up, maintaining safe burial performance, securing vaccine supply for frontline  workers, and maintaining cross-border surveillance and information sharing.


Source: World Health Organization, Regional Office for Africa, https://www.afro.who.int/countries/kenya/publication/ebola-bundibugyo-virus-disease-outbreak-democratic-republic-congo-uganda-weekly-external-situation

____

No comments:

Post a Comment

My New Space

Most Popular Posts